Antibodies able to block the omicron coronavirus variant last four months after a third dose of Pfizer-BioNTech’s vaccine, according to a study published Jan. 22 by bioRxiv.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News